These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32580117)

  • 1. A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women.
    Tsai MS; Chang SH; Kuo WH; Kuo CH; Li SY; Wang MY; Chang DY; Lu YS; Huang CS; Cheng AL; Lin CH; Chen PC
    Environ Int; 2020 Sep; 142():105850. PubMed ID: 32580117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfluorinated alkylated substances serum concentration and breast cancer risk: Evidence from a nested case-control study in the French E3N cohort.
    Mancini FR; Cano-Sancho G; Gambaretti J; Marchand P; Boutron-Ruault MC; Severi G; Arveux P; Antignac JP; Kvaskoff M
    Int J Cancer; 2020 Feb; 146(4):917-928. PubMed ID: 31008526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Premature Ovarian Insufficiency in Chinese Women.
    Zhang S; Tan R; Pan R; Xiong J; Tian Y; Wu J; Chen L
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2543-2551. PubMed ID: 29986037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental exposure to perfluoroalkyl substances in early pregnancy, maternal glucose homeostasis and the risk of gestational diabetes: A prospective cohort study.
    Yu G; Jin M; Huang Y; Aimuzi R; Zheng T; Nian M; Tian Y; Wang W; Luo Z; Shen L; Wang X; Du Q; Xu W; Zhang J;
    Environ Int; 2021 Nov; 156():106621. PubMed ID: 33984575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health.
    Tsai MS; Miyashita C; Araki A; Itoh S; Bamai YA; Goudarzi H; Okada E; Kashino I; Matsuura H; Kishi R
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29758015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal perfluorooctanoic acid exposure is associated with early onset atopic dermatitis in 5-year-old children.
    Wen HJ; Wang SL; Chuang YC; Chen PC; Guo YL
    Chemosphere; 2019 Sep; 231():25-31. PubMed ID: 31128349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort.
    Liew Z; Ritz B; von Ehrenstein OS; Bech BH; Nohr EA; Fei C; Bossi R; Henriksen TB; Bonefeld-Jørgensen EC; Olsen J
    Environ Health Perspect; 2015 Apr; 123(4):367-73. PubMed ID: 25616253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
    Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
    Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk and serum levels of per- and poly-fluoroalkyl substances: a case-control study nested in the California Teachers Study.
    Hurley S; Goldberg D; Wang M; Park JS; Petreas M; Bernstein L; Anton-Culver H; Nelson DO; Reynolds P
    Environ Health; 2018 Nov; 17(1):83. PubMed ID: 30482205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluoroalkyl substances exposure and risk of polycystic ovarian syndrome related infertility in Chinese women.
    Wang W; Zhou W; Wu S; Liang F; Li Y; Zhang J; Cui L; Feng Y; Wang Y
    Environ Pollut; 2019 Apr; 247():824-831. PubMed ID: 30731307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gestational exposure to perfluoroalkyl substances and congenital heart defects: A nested case-control pilot study.
    Ou Y; Zeng X; Lin S; Bloom MS; Han F; Xiao X; Wang H; Matala R; Li X; Qu Y; Nie Z; Dong G; Liu X
    Environ Int; 2021 Sep; 154():106567. PubMed ID: 33882431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
    Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
    Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal exposure to perfluoroalkyl substances and the risk of congenital cerebral palsy in children.
    Liew Z; Ritz B; Bonefeld-Jørgensen EC; Henriksen TB; Nohr EA; Bech BH; Fei C; Bossi R; von Ehrenstein OS; Streja E; Uldall P; Olsen J
    Am J Epidemiol; 2014 Sep; 180(6):574-81. PubMed ID: 25139206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer risk after exposure to perfluorinated compounds in Danish women: a case-control study nested in the Danish National Birth Cohort.
    Bonefeld-Jørgensen EC; Long M; Fredslund SO; Bossi R; Olsen J
    Cancer Causes Control; 2014 Nov; 25(11):1439-48. PubMed ID: 25148915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Chang VC; Rhee J; Berndt SI; Moore SC; Freedman ND; Jones RR; Silverman DT; Gierach GL; Hofmann JN; Purdue MP
    Int J Cancer; 2023 Aug; 153(4):775-782. PubMed ID: 36843273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum perfluoroalkyl substances and breast cancer risk in Japanese women: A case-control study.
    Itoh H; Harada KH; Kasuga Y; Yokoyama S; Onuma H; Nishimura H; Kusama R; Yokoyama K; Zhu J; Harada Sassa M; Tsugane S; Iwasaki M
    Sci Total Environ; 2021 Dec; 800():149316. PubMed ID: 34392213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative bias analysis of a reported association between perfluoroalkyl substances (PFAS) and endometriosis: The influence of oral contraceptive use.
    Ngueta G; Longnecker MP; Yoon M; Ruark CD; Clewell HJ; Andersen ME; Verner MA
    Environ Int; 2017 Jul; 104():118-121. PubMed ID: 28392065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study.
    Borghese MM; Walker M; Helewa ME; Fraser WD; Arbuckle TE
    Environ Int; 2020 Aug; 141():105789. PubMed ID: 32408216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between perfluoroalkyl substances and reproductive hormones in adolescents and young adults.
    Tsai MS; Lin CY; Lin CC; Chen MH; Hsu SH; Chien KL; Sung FC; Chen PC; Su TC
    Int J Hyg Environ Health; 2015 Jul; 218(5):437-43. PubMed ID: 25921520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.